Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part I.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
Jan 2021
Historique:
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 20 2 2021
Statut: ppublish

Résumé

The summary presented herein represents Part I of the two-part series dedicated to the Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. Part I outlines the appropriate evaluation of the male in an infertile couple. Recommendations proceed from obtaining an appropriate history and physical exam (Appendix I), as well as diagnostic testing, where indicated. The Emergency Care Research Institute Evidence-based Practice Center team searched PubMed®, Embase®, and Medline from January, 2000 through May, 2019. When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, additional information is provided as Clinical Principles and Expert Opinions (table 1[Table: see text]). This summary is being simultaneously published in Fertility and Sterility and The Journal of Urology. This Guideline provides updated, evidence-based recommendations regarding evaluation of male infertility as well as the association of male infertility with other important health conditions. The detection of male infertility increases the risk of subsequent development of health problems for men. In addition, specific medical conditions are associated with some causes for male infertility. Evaluation and treatment recommendations are summarized in the associated algorithm (figure[Figure: see text]). The presence of male infertility is crucial to the health of patients and its effects must be considered for the welfare of society. This document will undergo updating as the knowledge regarding current treatments and future treatment options continues to expand.

Identifiants

pubmed: 33295257
doi: 10.1097/JU.0000000000001521
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-43

Auteurs

Peter N Schlegel (PN)

New York Presbyterian Hospital-Weill Cornell Medical College.

Mark Sigman (M)

Brown University School of Medicine.

Christopher J De Jonge (CJ)

University of Minnesota School of Medicine.

Michael L Eisenberg (ML)

Stanford University School of Medicine.

Dolores J Lamb (DJ)

Weill Cornell Medicine.

John P Mulhall (JP)

Memorial-Sloan Kettering Cancer Center.

Craig Niederberger (C)

University of Illinois-Chicago School of Medicine.

Rebecca Z Sokol (RZ)

University of Southern California Keck School of Medicine.

Steven D Spandorfer (SD)

Weill Cornell Medicine.

Cigdem Tanrikut (C)

Georgetown University School of Medicine.

Armand Zini (A)

McGill University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH